GPX1 and breast cancer: Docosahexaenoic acid dietary supplementation increases tumor sensitivity to anthracyclines by reducing cytosolic GPX1 activity in breast cancer cell line MDA-MB-231 and rat mammary tumors, which can be abolished by vitamin E [81].